Skip to main content
. 2022 Mar 8;10:823933. doi: 10.3389/fbioe.2022.823933

FIGURE 5.

FIGURE 5

DSF significantly reduced fibroblast activation and proliferation after BMDM exosome treatment. NIH/3T3 fibroblasts were cultured and treated with macrophage-derived exosomes. Cells were pretreated with DSF (5 μM) or DMSO (0.01%) for 2 h. (A,B) Western blot (A) and quantitative (B) analyses of FN, Col-I, and α-SMA in fibroblast from control, exosomes, and exosomes in the presence of DSF. (C) Quantitative analysis of EdU incorporation in fibroblast from control, exosomes, and exosomes in the presence of DSF. (D,E) FACS (D) and quantitative (E) analysis of cell cycle in fibroblast from control, exosomes, and exosomes in the presence of DSF. (F,G) The picture (F) and quantitative analysis (G) of the cell migration in fibroblast from control, exosomes, and exosomes in the presence of DSF. Scale bar = 20 μm. (H,I) The picture (H) and quantitative analysis (I) of the cell wound scratch assay in fibroblast from control, exosomes, and exosomes in the presence of DSF. Scale bar = 20 μm. Data are presented as the mean ± SEM (n = 3) (B,C,E,G,I). *p < 0.05.